Abstract
We present a patient with progressive spastic ataxia, with dystonia and anarthria undiagnosed until detailed genetic analysis revealed an MPAN mutation. Highlighting the worldwide MPAN distribution, a 30year history of absent diagnosis and the impact and cost saving of an early but detailed genetic analysis in complex progressive movement disorders, particularly the anarthric NBIA group.
Keywords:
C19orf12; NBIA; Spastic ataxia; TruSight panels.
Copyright © 2017 Elsevier B.V. All rights reserved.
MeSH terms
-
Adult
-
Female
-
Humans
-
Intellectual Disability / diagnostic imaging*
-
Intellectual Disability / genetics*
-
Mitochondrial Membrane Transport Proteins / genetics*
-
Mitochondrial Proteins / genetics*
-
Muscle Spasticity / diagnostic imaging*
-
Muscle Spasticity / genetics*
-
Optic Atrophy / diagnostic imaging*
-
Optic Atrophy / genetics*
-
Russia
-
Spinocerebellar Ataxias / diagnostic imaging*
-
Spinocerebellar Ataxias / genetics*
-
Time Factors
Substances
-
C19orf12 protein, human
-
Mitochondrial Membrane Transport Proteins
-
Mitochondrial Proteins